The funding aligns with the in-licensing of SLTE-1009, an anti-PACAP monoclonal antibody acquired from DartsBio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results